Alimera Sciences, Inc. (ALIM) financial statements (2020 and earlier)

Company profile

Business Address 6120 WINDWARD PARKWAY
ALPHARETTA, GA 30005
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments9132431317713
Cash and cash equivalents9132431317713
Restricted cash and investments00000  
Receivables191711141011
Inventory, net of allowances, customer advances and progress billings1220222
Inventory1220222
Deferred costs     10
Prepaid expense and other current assets3
Other undisclosed current assets322233 
Total current assets:33353947458319
Noncurrent Assets
Finance lease, right-of-use asset0
Operating lease, right-of-use asset1
Property, plant and equipment 112321
Intangible assets, net (including goodwill)151719212324
Intangible assets, net (excluding goodwill)151719212324 
Deferred income tax assets1
Deferred tax assets, net   000
Other undisclosed noncurrent assets1110 (0)(0)
Total noncurrent assets:1819212325261
TOTAL ASSETS:505460707010920
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities121099863
Accounts payable7665452
Accrued liabilities5444411
Taxes payable      0
Interest and dividends payable     0 
Debt00003212
Derivative instruments and hedges, liabilities   0 1616
Deferred tax liabilities    00
Other undisclosed current liabilities    0(13)(16)
Total current liabilities:121010940105
Noncurrent Liabilities
Long-term debt and lease obligation0035331333
Long-term debt, excluding current maturities  3433 333
Finance lease, liability0
Capital lease obligations000100
Liabilities, other than long-term debt4312100
Other liabilities4312100
Total noncurrent liabilities:4335361333
Total liabilities:1614454541448
Stockholders' equity
Stockholders' equity attributable to parent, including:(4)315262650(5)
Common stock01  000
Additional paid in capital350346342331299293240
Accumulated other comprehensive loss(1)(1)(1)(1)(1)(1)(0)
Accumulated deficit(388)(377)(399)(377)(344)(313)(277)
Warrants and rights outstanding44     
Other undisclosed stockholders' equity attributable to parent30307373727032
Total stockholders' equity:(4)315262650(5)
Other undisclosed liabilities and equity3938  31616
TOTAL LIABILITIES AND EQUITY:505460707010920

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues544736342282
Cost of revenue
(Cost of Goods and Services Sold)
(7) (3)(2)(2)(1)(2)
Other undisclosed gross profit (5)    0
Gross profit:474232322170
Operating expenses(53)(52)(49)(60)(60)(40)(34)
Operating loss:(5)(10)(16)(28)(39)(33)(34)
Nonoperating income (expense)
(Foreign Currency Transaction Gain (Loss), before Tax)
(0)(0)0(0)(0)(1) 
Interest and debt expense(5)(7)(6)(8)(5)(3)(1)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes  03130(11)
Loss from continuing operations before equity method investments, income taxes:(10)(16)(22)(33)(31)(36)(46)
Other undisclosed loss from continuing operations before income taxes     (0) 
Loss from continuing operations before income taxes:(10)(16)(22)(33)(31)(36)(46)
Income tax expense(0)(0)(0)(0)(0)(0) 
Net loss attributable to parent:(10)(16)(22)(33)(31)(36)(46)
Preferred stock dividends and other adjustments 38     
Undistributed earnings (loss) allocated to participating securities, basic 4 
Other undisclosed net loss available to common stockholders, basic (4)   (1)(5)
Net income (loss) available to common stockholders, diluted:(10)22(22)(33)(31)(37)(51)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(10)(16)(22)(33)(31)(36)(46)
Other comprehensive income (loss)(0)(0)0(0)(0)(0)(0)
Comprehensive loss, net of tax, attributable to parent:(11)(17)(22)(33)(31)(36)(47)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: